Koichiro Kimura
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Tumor and Organ Dose Estimates from 177Lu-PSMA-617 Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: Results from the RESIST-PC Phase 2 Trial.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: March 23, 2026
[68Ga]Ga-FAPI-46 PET/CT in Adrenocortical Neoplasm, Oncocytic Type.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: November 13, 2025
Diagnostic value of MRI-ultrasound fusion-targeted prostate biopsy for non-index lesions combined with the index lesion biopsy.
Journal: Urologic oncology
Published: October 16, 2025
Dosimetry Analysis of 177Lu-PSMA-I&T in Patients with Low-Volume Oligometastatic Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the LUNAR Trial.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: October 13, 2025
Time-dependent Treatment Effects of Prostate-specific Membrane Antigen Radioligand Therapy in Metastatic Castration-resistant Prostate Cancer in the ENZA-p (ANZUP1901) Trial.
Journal: European urology focus
Published: September 14, 2025
Phase 2 Prospective Trial of Retreatment with [177Lu]Lu-PSMA-617 Molecular Radiotherapy for Metastatic Castration-Resistant Prostate Cancer-RE-LuPSMA.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 08, 2025
Postoperative routine computed tomography allows detection of early-stage acute exacerbations of interstitial pneumonia.
Journal: Journal of thoracic disease
Published: September 02, 2025
Linking Baseline PSMA PET-Derived Parameters to Toxicity, Adverse Events, Pain, and Quality of Life in Patients Treated with [177Lu]Lu-PSMA-617: A Single-Center Retrospective Study.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 22, 2025
PSMA PET/CT-Derived Indicators and Outcomes After [177Lu]Lu-PSMA-617: A Multicenter Retrospective Analysis from the U.S. Expanded-Access Program.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 06, 2025
Liquid Biopsy of Circulating Tumor Cells and DNA in the Context of PSMA Radiopharmaceutical Therapy.
Liquid Biopsy of Circulating Tumor Cells and DNA in the Context of PSMA Radiopharmaceutical Therapy.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: June 17, 2025
Evaluating the Volume of Eyes With Pathologic Myopia Using 3D MRI.
Journal: Investigative ophthalmology & visual science
Published: April 07, 2025
Prognostic Value of AI-Assisted Lesion Tracking on End-of-Treatment PSMA PET in mCRPC Patients Treated with 177Lu-PSMA: A Retrospective, Single-Center Study.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: March 20, 2025
Last Updated: 09/26/2026